Further Lessons in Pneumocystis Pneumonia Prophylaxis
نویسندگان
چکیده
منابع مشابه
Treatment and prophylaxis of Pneumocystis carinii pneumonia.
Trimethoprim-sulfamethoxazole and parenteral pentamidine isethionate are effective in 60 to 80 per cent of AIDS patients with pneumocystis pneumonia. Adverse reactions are frequent with both agents, but because the adverse reactions are less severe with trimethoprim-sulfamethoxazole, this agent is the drug of choice for patients who are not known to be intolerant of it. The recommended duration...
متن کاملRoutine pneumocystis pneumonia prophylaxis in patients treated with rituximab?
journal.publications.chestnet.org Figure 1. Proposed relationship among pulmonary infl ammation, systemic infl ammation, and COPDrelated comorbidities. *Statins have been shown to attenuate both pulmonary and systemic infl ammation through their effects on the innate immune response and NF k B/STAT3-mediated infl ammatory pathways. CRP 5 C-reactive protein; ETS 5 environmental tobacco smoke; M ...
متن کاملUse of fluoroquinolones for prophylaxis of murine Pneumocystis carinii pneumonia.
We compared the prophylactic activities of six fluoroquinolones against Pneumocystis carinii pneumonia in immunosuppressed rats. Pefloxacin was the only agent which was as effective as the reference drug trimethoprim-sulfamethoxazole. Clinical trials with pefloxacin in patients at risk for P. carinii pneumonia appear to be justified.
متن کاملSystemic Pneumocystis carinni pneumonia prophylaxis with dapsone and pyrimethamine fails
Extrapulmonary pneumocystosis is a feature of severe immunosuppression which earlier reports have suggested is limited to patients receiving either no prophylaxis or aerosolised pentamidine. We report a case of disseminated pneumocystosis which developed in an HIV positive homosexual man despite systemic primary Pneumocystis carinii pneumo-
متن کاملPassive intranasal monoclonal antibody prophylaxis against murine Pneumocystis carinii pneumonia.
Passive antibody immunoprophylaxis is one method used to protect patients against infection if they are unable to mount an adequate active immune response. Topical application of antibody may be effective against infections at mucosal sites. Using a SCID mouse model of Pneumocystis carinii pneumonia, we were able to demonstrate protection against an airborne challenge with P. carinii by intrana...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: JAMA Internal Medicine
سال: 2018
ISSN: 2168-6106
DOI: 10.1001/jamainternmed.2018.5930